Abstract
Dendritic cells are rare haematopoietic cells that reside in a number of organs and tissues. By capturing, processing and presenting antigens to T cells, dendritic cells are essential for immune surveillance and the regulation of specific immunity1,2,3,4. Several members of the tumour necrosis factor receptor (TNFR) superfamily are integral to the regulation of the immune response. These structurally related proteins modulate cellular functions ranging from proliferation and differentiation to inflammation and cell survival or death5,6. The functional activity of dendritic cells is greatly increased by signalling through the TNFR family member CD40 (refs 7, 8). Here we report the characterization of RANK (for receptor activator of NF-κB), a new member of the TNFR family derived from dendritic cells, and the isolation of a RANK ligand (RANKL) by direct expression screening. RANKL augments the ability of dendritic cells to stimulate naive T-cell proliferation in a mixed lymphocyte reaction, and increases the survival of RANK+T cells generated with interleukin-4 and transforming growth factor (TGF)-β. Thus RANK and RANKL seem to be important regulators of interactions between T cells and dendritic cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Steinmann, R. M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9, 271–296 (1991).
Caux, C. & Banchereau, J. in Blood Cell Biochemistry Vol. 7,Hemopoietic growth factors and their receptors (eds Whetton, A. & Gordon, J.) 263 (Plenum, London, (1996)).
Dubois, B. et al. Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes. J. Exp. Med. 185, 941–951 (1997).
Austyn, J. M. New insights into the mobilization and phagocytic activity of dendritic cells. J. Exp. Med. 183, 1287–1292 (1996).
Smith, C. A., Farrah, T. & Goodwin, R. G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76, 959–962 (1994).
Baker, S. J. & Reddy, E. P. Transducers of life and death: TNF superfamily and associated proteins. Oncogene 12, 1–9 (1996).
Caux, C. et al. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180, 1263–1272 (1994).
Cella, M. et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184, 747–752 (1996).
Armitage, R. J. et al. Molecular and biological characterization of a murine ligand for CD40. Nature 357, 80–82 (1992).
Baeuerle, P. A. & Henkel, T. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12, 141–179 (1994).
Rothe,, Sarma, V., Dixit, V. M. & Goeddel, D. V. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269, 1424–1427 (1995).
Armitage, R. J. Tumor necrosis factor receptor superfamily members and their ligands. Curr. Opin. Immunol. 6, 407–413 (1994).
de Jong, R. et al. Differential effect of transforming growth factor-β1 on the activation of human naive and memory CD4+ T lymphocytes. Int. Immunol. 6, 631–638 (1994).
Fukaura, H. et al. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J. Clin. Invest. 98, 70–77 (1996).
Weiner, H. L. et al. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12, 809–837 (1994).
Madsen, M., Johnsen, H. E., Hansen, P. W. & Christiansen, S. E. Isolation of human T and B lymphocytes by E-rosette gradient centrifugation. Characterization of the isolated subpopulations. J.Immunol. Methods 33, 323–336 (1980).
Larsen, A. et al. Expression cloning of a human granulocyte colony-stimulating factor receptor: a structural mosaic of hematopoietin receptor, immunoglobulin, and fibronectin domains. J. Exp. Med. 172, 1559–1570 (1990).
Anderson, D. M. et al. Functional characterization of the human interleukin-15 receptor α chain and close linkage of IL15RA and IL2RA genes. J. Biol. Chem. 270, 29862–29869 (1995).
Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J.Mol. Biol. 215, 403–410 (1990).
Idzerda, R. L. et al. Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily. J. Exp. Med. 171, 861–873 (1990).
Goodwin, R. G. et al. Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily. Cell 60, 941–951 (1990).
Giri, J. G. et al. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13, 2822–2830 (1994).
McMahan, C. J. et al. Anovel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10, 2821–2832 (1991).
Baum, P. R. et al. Molecular characterization of murine and human OX40/OX40 ligand systems: identiffication of a human OX40 ligand as the HTLV-1 regulated protein gp34. EMBO J. 13, 3992–4001 (1994).
Hoffmann, A. & Roeder, R. G. Purification of his-tagged proteins in non-denaturing conditions suggests a convenient method for protein interaction studies. Nucleic Acids Res. 19, 6337–6338 (1991).
Goodwin, R. G. et al. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 73, 447–456 (1993).
Walter, M. A., Spillett, D. J., Thomas, P., Weisenbach, J. & Goodfellow, P. N. Amethod for constructing radiation hybrid maps of whole genomes. Nature Genet. 7, 22–28 (1994).
Mosley, B. et al. The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell 59, 335–348 (1989).
Yao, Z. et al. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3, 811–821 (1995).
Wong, B. R. et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272, 25190–25194 (1997).
Acknowledgements
We thank L. T. Hollingsworth, C.-P. Huang, M. S. Timour and J. S. Bertles for DNA sequencing; S. C. Braddy and D. E. Hirschstein for cell sorting; M. J. Petersen, S. A. Sherer, Z. Sadeghi and P. J. Smolak for technical assistance; M. Hall for graphical assistance; A. Bannister for editorial assistance; and M. Caligiuri of the Roswell Park Cancer Institute for human bone-marrow samples.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Anderson, D., Maraskovsky, E., Billingsley, W. et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390, 175–179 (1997). https://doi.org/10.1038/36593
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/36593
This article is cited by
-
The progressive trend of modeling and drug screening systems of breast cancer bone metastasis
Journal of Biological Engineering (2024)
-
Restrained Mitf-associated autophagy by Mulberroside A ameliorates osteoclastogenesis and counteracts OVX-Induced osteoporosis in mice
Cell Death Discovery (2024)
-
Comparative study of the synovial levels of RANKL and OPG in rheumatoid arthritis, spondyloarthritis and osteoarthritis
Advances in Rheumatology (2023)
-
Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors
Nature Communications (2023)
-
Pathogenesis of allergic diseases and implications for therapeutic interventions
Signal Transduction and Targeted Therapy (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.